Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 23820374)

1.

Cristalius: a case in designer drugs.

Lenz J, Brown J, Flagg S, Oh R, Batts K, Ditzler T, Johnson J.

Mil Med. 2013 Jul;178(7):e893-5. doi: 10.7205/MILMED-D-12-00393.

PMID:
23820374
2.

Emergency department visits after use of a drug sold as "bath salts"--Michigan, November 13, 2010-March 31, 2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 May 20;60(19):624-7.

3.

Bath salts: they are not what you think.

Wieland DM, Halter MJ, Levine C.

J Psychosoc Nurs Ment Health Serv. 2012 Feb;50(2):17-21.

PMID:
22439144
4.

"Bath salts" and "plant food" products: the experience of one regional US poison center.

Murphy CM, Dulaney AR, Beuhler MC, Kacinko S.

J Med Toxicol. 2013 Mar;9(1):42-8. doi: 10.1007/s13181-012-0243-1.

5.

Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.

Ross EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA.

Am J Med. 2012 Sep;125(9):854-8. doi: 10.1016/j.amjmed.2012.02.019. Epub 2012 Jun 9. Review.

PMID:
22682791
6.

Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following "bath salts" injection.

Sutamtewagul G, Sood V, Nugent K.

Clin Nephrol. 2014 Jan;81(1):63-6.

PMID:
24356039
7.

Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.

Thornton SL, Gerona RR, Tomaszewski CA.

J Med Toxicol. 2012 Sep;8(3):310-3. doi: 10.1007/s13181-012-0232-4.

8.

Illicit bath salts: not for bathing.

Kyle PB, Iverson RB, Gajagowni RG, Spencer L.

J Miss State Med Assoc. 2011 Dec;52(12):375-7.

PMID:
22329114
9.

[Mephedrone, the new designer drug of abuse: pharmacokinetics, pharmacodynamics and clinical and forensic issues].

Ribeiro E, Magalhães T, Dinis-Oliveira RJ.

Acta Med Port. 2012 Mar-Apr;25(2):111-7. Epub 2012 Jun 25. Review. Portuguese.

10.

Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.

Spiller HA, Ryan ML, Weston RG, Jansen J.

Clin Toxicol (Phila). 2011 Jul;49(6):499-505. doi: 10.3109/15563650.2011.590812.

PMID:
21824061
11.

The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).

Dargan PI, Sedefov R, Gallegos A, Wood DM.

Drug Test Anal. 2011 Jul-Aug;3(7-8):454-63. doi: 10.1002/dta.312. Epub 2011 Jul 13. Review.

PMID:
21755604
12.

Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project.

Bäckberg M, Lindeman E, Beck O, Helander A.

Clin Toxicol (Phila). 2015 Jan;53(1):46-53. doi: 10.3109/15563650.2014.981823. Epub 2014 Nov 25.

PMID:
25422862
13.

[Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].

Zawilska JB, Słomiak K, Wasiak M, Woźniak P, Massalski M, Krupa E, Wojcieszak JŁ.

Przegl Lek. 2013;70(6):386-91. Polish.

PMID:
24052975
14.

Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

Murray BL, Murphy CM, Beuhler MC.

J Med Toxicol. 2012 Mar;8(1):69-75. doi: 10.1007/s13181-011-0196-9.

15.

Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.

Blum K, Foster Olive M, Wang KK, Febo M, Borsten J, Giordano J, Hauser M, Gold MS.

Med Hypotheses. 2013 Sep;81(3):450-5. doi: 10.1016/j.mehy.2013.06.007. Epub 2013 Jul 8.

PMID:
23845561
16.

[Mephedrone: a designer drug of recent use in France].

Debruyne D, Courné MA, Le Boisselier R, Djezzar S, Gérardin M, Boucher A, Karila L, Coquerel A, Mallaret M.

Therapie. 2010 Nov-Dec;65(6):519-24. Epub 2010 Dec 23. Review. French.

PMID:
21176758
17.

Riding high on cloud 9.

Caffery T, Musso M, Manausa R, Everett J, Perret J.

J La State Med Soc. 2012 Jul-Aug;164(4):186-9.

PMID:
22953454
18.

Hyperthermia and multiorgan failure after abuse of "bath salts" containing 3,4-methylenedioxypyrovalerone.

Borek HA, Holstege CP.

Ann Emerg Med. 2012 Jul;60(1):103-5. doi: 10.1016/j.annemergmed.2012.01.005. Epub 2012 Mar 3.

PMID:
22387085
19.

Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.

Cameron K, Kolanos R, Vekariya R, De Felice L, Glennon RA.

Psychopharmacology (Berl). 2013 Jun;227(3):493-9. doi: 10.1007/s00213-013-2967-2. Epub 2013 Jan 31. Erratum in: Psychopharmacology (Berl). 2013 Jun;227(3):447. Verkariya, Rakesh [corrected to Vekariya, Rakesh].

20.

Designer cathinones--an emerging class of novel recreational drugs.

Zawilska JB, Wojcieszak J.

Forensic Sci Int. 2013 Sep 10;231(1-3):42-53. doi: 10.1016/j.forsciint.2013.04.015. Epub 2013 May 10.

PMID:
23890615
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk